BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36367755)

  • 1. Drug-associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance database.
    Konstantinov K; Dolladille C; Gillet B; Alexandre J; Aouba A; Deshayes S; Repesse Y
    Haemophilia; 2023 Jan; 29(1):186-192. PubMed ID: 36367755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.
    Salem JE; Manouchehri A; Moey M; Lebrun-Vignes B; Bastarache L; Pariente A; Gobert A; Spano JP; Balko JM; Bonaca MP; Roden DM; Johnson DB; Moslehi JJ
    Lancet Oncol; 2018 Dec; 19(12):1579-1589. PubMed ID: 30442497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Toxicities Associated With Ibrutinib.
    Salem JE; Manouchehri A; Bretagne M; Lebrun-Vignes B; Groarke JD; Johnson DB; Yang T; Reddy NM; Funck-Brentano C; Brown JR; Roden DM; Moslehi JJ
    J Am Coll Cardiol; 2019 Oct; 74(13):1667-1678. PubMed ID: 31558250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study.
    Johnson DB; Manouchehri A; Haugh AM; Quach HT; Balko JM; Lebrun-Vignes B; Mammen A; Moslehi JJ; Salem JE
    J Immunother Cancer; 2019 May; 7(1):134. PubMed ID: 31118078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric antigen receptor T-cells safety: A pharmacovigilance and meta-analysis study.
    Dolladille C; Ederhy S; Ezine E; Choquet S; Nguyen LS; Alexandre J; Moslehi JJ; Dechartres A; Salem JE
    Am J Hematol; 2021 Sep; 96(9):1101-1111. PubMed ID: 34057232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs associated with epidermal necrolysis in children: A World Health Organization pharmacovigilance database analysis.
    Bataille P; Lebrun-Vignes B; Bettuzzi T; Ingen-Housz-Oro S; Hadj-Rabia S; Welfringer-Morin A; Bodemer C
    J Eur Acad Dermatol Venereol; 2024 Apr; ():. PubMed ID: 38682703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4/13 Blockade and sleep-related adverse drug reactions in over 37,000 Dupilumab reports from the World Health Organization Individual Case Safety reporting pharmacovigilance database (VigiBase™): a big data and machine learning analysis.
    Alroobaea R; Rubaiee S; Hanbazazah AS; Jahrami H; Garbarino S; Damiani G; Wu J; Bragazzi NL
    Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):4074-4081. PubMed ID: 35731078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and characteristics of chemotherapy-associated thrombotic microangiopathy: Analysis from a large pharmacovigilance database.
    Klomjit N; Evans R; Le TK; Wells SL; Ortega J; Green-Lingren O; Mazepa M; Sise ME; Jhaveri KD; Gupta S
    Am J Hematol; 2023 Dec; 98(12):E369-E372. PubMed ID: 37740927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced delusion: A comprehensive overview of the WHO pharmacovigilance database.
    Balcerac A; Baldacci A; Romier A; Annette S; Lemarchand B; Bihan K; Bottemanne H
    Psychiatry Res; 2023 Sep; 327():115365. PubMed ID: 37517106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database.
    Montastruc JL; Lafaurie M; de Canecaude C; Durrieu G; Sommet A; Montastruc F; Bagheri H
    Br J Clin Pharmacol; 2021 Nov; 87(11):4334-4340. PubMed ID: 33837554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities.
    Allenbach Y; Anquetil C; Manouchehri A; Benveniste O; Lambotte O; Lebrun-Vignes B; Spano JP; Ederhy S; Klatzmann D; Rosenzwajg M; Fautrel B; Cadranel J; Johnson DB; Moslehi JJ; Salem JE
    Autoimmun Rev; 2020 Aug; 19(8):102586. PubMed ID: 32535094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.
    Salem JE; Nguyen LS; Moslehi JJ; Ederhy S; Lebrun-Vignes B; Roden DM; Funck-Brentano C; Gougis P
    Eur Heart J; 2021 Oct; 42(38):3915-3928. PubMed ID: 34370839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping endocrine toxicity spectrum of immune checkpoint inhibitors: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
    Bai X; Lin X; Zheng K; Chen X; Wu X; Huang Y; Zhuang Y
    Endocrine; 2020 Sep; 69(3):670-681. PubMed ID: 32507965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
    Svendsen K; Wood M; Olsson E; Nordeng H
    Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase®.
    Pokladnikova J; Meyboom RH; Meincke R; Niedrig D; Russmann S
    Drug Saf; 2016 May; 39(5):455-64. PubMed ID: 26936182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database.
    Arnaud L; Mertz P; Gavand PE; Martin T; Chasset F; Tebacher-Alt M; Lambert A; Muller C; Sibilia J; Lebrun-Vignes B; Salem JE
    Ann Rheum Dis; 2019 Apr; 78(4):504-508. PubMed ID: 30793701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
    Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
    Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sipuleucel-T associated inflammatory cardiomyopathy: a case report and observations from a large pharmacovigilance database.
    Moey MYY; Jiwani RA; Takeda K; Prenshaw K; Kreeger RW; Inzerillo J; Liles DK; Marcu CB; Lebrun-Vignes B; Morris DL; Ardhanari S; Salem JE
    ESC Heart Fail; 2021 Aug; 8(4):3360-3368. PubMed ID: 33938158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database.
    Hoisnard L; Lebrun-Vignes B; Maury S; Mahevas M; El Karoui K; Roy L; Zarour A; Michel M; Cohen JL; Amiot A; Claudepierre P; Wolkenstein P; Grimbert P; Sbidian E
    Sci Rep; 2022 May; 12(1):7140. PubMed ID: 35504889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review.
    De Las Cuevas C; Arrojo-Romero M; Ruan CJ; Schoretsanitis G; Sanz EJ; de Leon J
    Expert Opin Drug Metab Toxicol; 2022 Nov; 18(11):715-727. PubMed ID: 36526610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.